New study tracks best breast cancer treatment for younger women
NCT ID NCT05792150
First seen Jun 27, 2026 · Last updated Aug 06, 2026 · Updated 2 times
Summary
This study follows premenopausal women with a common type of early breast cancer to see how well different treatments work over time. Participants either receive hormone therapy (with or without ovarian suppression) or chemotherapy followed by hormone therapy. The goal is to understand which approach leads to better long-term outcomes and quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,470 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2022
- Expected to finish
-
Jun 2035
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
For this registry, it is planned to screen N=3000 pre- and perimenopausal patients with early breast cancer who meet the inclusion criteria, i.e., intermediate to high clinical risk for recurrence, and who will receive or have received a routine genomic testing by MammaPrint® with a low/ultralow genomic risk. It is anticipated that 75% of these patients will be nodal negative and 25% nodal positive.
- Ages
-
18 to 60 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Patients are eligible for participation in the registry only if they meet all the following criteria: * Female breast cancer patients * Pre- or perimenopausal at registry entry (age \<60 years and state after hysterectomy or amenorrhea for \<12 months; confirmation by blood hormone levels (FSH and estradiol in premenopausal range as per local normal range) recommended) * Primary tumor diagnosis not older than three months prior to inclusion (primary diagnosis defined as date of initial tumor biopsy) * Estrogen- and/or progesterone-receptor-positive/HER2 negative early breast cancer without any clinical signs of metastases * Adequate risk for recurrence: * intermediate clinical risk for recurrence, defined as (clinical in case of neoadjuvant treatment): * c/pT1 and * c/pN0 and * Ki-67 15-24% or * G2 or * patients, who do not meet these criteria but are at intermediate clinical risk for recurrence at investigator decision (e.g., very young age, low expression of hormone receptors, existing co-morbidities, familial cancer burden, etc.) can be included on individual decision basis or * high clinical risk for recurrence, defined as either (clinical in case of neoadjuvant treatment): * c/pT2-4 or * c/pN1 or * Ki-67 ≥25% or * G3 * Low genomic risk of recurrence by MammaPrint® (tested on treatment naïve tumor specimen) * Luminal-type by BluePrint® * Treatment according to standard-of-care (e.g., AGO Guidelines) planned or started (until completion of local therapy the latest (including started or completed endocrine induction therapy), started, or planned adjuvant or neoadjuvant treatment) * Availability of untreated tumor material (core biopsy if preoperative endocrine therapy performed or neoadjuvant treatment intended or surgery specimen) * Capability to give written informed consent * Nodal positive patients will be accepted to the registry up to 25% of the genomic low/ultralow-risk population (n=441). Exclusion Criteria: Patients will not be eligible for the registry for any of the following reasons: * Any other genomic testing, besides MammaPrint®, has been performed on the tumor material * Medical or psychological conditions that would not permit the patient to sign informed consent * Legal incapacity or limited legal capacity * Current participation in any interventional clinical trial which tests anticancer drugs, immunotherapeutics, or antibody treatment for any type of neoplasm * Non-compliance of the patient
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Early breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
61 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
AGAPLESION Allgemeines Krankenhaus Hagen
RECRUITINGHagen, North Rhine-Westphalia, 58095, Germany
-
AGAPLESION Diakonie Hamburg
RECRUITINGHamburg, Free and Hanseatic City of Hamburg, 20259, Germany
-
Altmark- Klinikum
RECRUITINGHansestadt Salzwedel, Saxony-Anhalt, 29410, Germany
-
Asklepios Klinik Barmbek
RECRUITINGHamburg, Free and Hanseatic City of Hamburg, 22307, Germany
-
Brustzentrum Niederrhein, Johanniter Bethesda Krankenhaus
RECRUITINGMönchengladbach, North Rhine-Westphalia, 41061, Germany
-
Caritas-Krankenhaus St. Josef, Klinik für Frauenheilkunde & Geburtshilfe
RECRUITINGRegensburg, Bavaria, 93053, Germany
-
Christliches Klinikum Unna gGmbH
RECRUITINGUnna, North Rhine-Westphalia, 59423, Germany
-
DIAKO Ev. Diakonie-Krankenhaus gemeinnützige GmbH
RECRUITINGBremen, Free Hanseatic City of Bremen, 28239, Germany
-
DIAKOVERE Henriettenstift
RECRUITINGHanover, Lower Saxony, 30171, Germany
-
DRK Kliniken Berlin Köpenick
RECRUITINGBerlin, State of Berlin, 12559, Germany
-
Diakonieklinikum Stuttgart, Brustzetrum
ACTIVE_NOT_RECRUITINGStuttgart, Baden-Wurttemberg, 70176, Germany
-
Elisabethkrankenhaus Kassel, Brustzentrum
RECRUITINGKassel, Hesse, 34117, Germany
-
Evang. Kliniken Essen Mitte, Interdisziplinäres Brustkrebszentrum
RECRUITINGEssen, North Rhine-Westphalia, 45136, Germany
-
Evangelisches Krankenhaus BETHESDA zu Duisburg GmbH, Brustzentrum
RECRUITINGDuisburg, North Rhine-Westphalia, 47053, Germany
-
Evangelisches Krankenhaus Wesel GmbH
RECRUITINGWesel, North Rhine-Westphalia, 46485, Germany
-
Frauenklinik St. Louise - St. Vincenz-Krankenhaus GmbH
RECRUITINGPaderborn, North Rhine-Westphalia, 33098, Germany
-
GRN Klinik Weinheim/ Gynäkologie/Brustzentrum
RECRUITINGWeinheim, Baden-Wurttemberg, 69469, Germany
-
Gemeinschaftskrankenhaus Herdecke gemeinnützige GmbH
RECRUITINGHerdecke, North Rhine-Westphalia, 58313, Germany
-
Gemeinschaftskrankenhaus/ Brustzentrum Havelhöhe
RECRUITINGBerlin, Brandenburg, 14089, Germany
-
Gesundheitszentrum Wetterau gGmbH Hochwaldkrankenhaus Bad Nauheim
RECRUITINGBad Nauheim, Hesse, 61231, Germany
-
Gynäkologische Praxisklinik Hamburg-Harburg
RECRUITINGHamburg, Free and Hanseatic City of Hamburg, 21073, Germany
-
Gynäkologische- Geburtshilfliche Klinik
RECRUITINGBad Soden am Taunus, Hesse, 65812, Germany
-
Gynäkologisches Zentrum
ACTIVE_NOT_RECRUITINGBonn, North Rhine-Westphalia, 53111, Germany
-
HOP Gemeinschaftspraxis Dres. Heinrich/Bangerter, Augsburg
RECRUITINGAugsburg, Bavaria, 86150, Germany
-
Helios Klinikum Krefeld, Zentrum für Ambulante Gynäkologische Onkologie - Studienabteilung
RECRUITINGKrefeld, Germany
-
Helios Klinikum Pforzheim, Brustzentrum
RECRUITINGPforzheim, Baden-Wurttemberg, 75175, Germany
-
Helios Klinikum Wuppertal
RECRUITINGWuppertal, North Rhine-Westphalia, 42283, Germany
-
Hämatologie/Onkologie Praxis
RECRUITINGBremen, Free Hanseatic City of Bremen, 28209, Germany
-
Katholisches Klinikum Lünen/Werne
RECRUITINGLünen, North Rhine-Westphalia, 44534, Germany
-
Kliniken der Stadt Köln
RECRUITINGCologne, North Rhine-Westphalia, 51067, Germany
-
Klinikum Bremerhaven Reinkenheide
RECRUITINGBremerhaven, Free Hanseatic City of Bremen, 27574, Germany
-
Klinikum Dortmund gGmbH, Beurhausstr.40
RECRUITINGDortmund, North Rhine-Westphalia, 44137, Germany
-
Klinikum Fürstenfeldbruck, Westdeutsches Brust- Centrum
RECRUITINGFürstenfeldbruck, Bavaria, 82256, Germany
-
Klinikum Hanau GmbH
ACTIVE_NOT_RECRUITINGHanau, Hesse, 63450, Germany
-
Klinikum Leverkusen, Am Gesundheitspark
RECRUITINGLeverkusen, North Rhine-Westphalia, 51375, Germany
-
Klinikum Luckenwalde
RECRUITINGLuckenwalde, Brandenburg, 14943, Germany
-
Klinikum St. Marien Amberg
RECRUITINGAmberg, Bavaria, 9224, Germany
-
Klinikum Südstadt
RECRUITINGRostock, Mecklenburg-Vorpommern, 18059, Germany
-
Klinikum Traunstein, Frauenklinik Südostbayern
RECRUITINGTraunstein, Germany
-
Klinikum Worms
RECRUITINGWorms, Rhineland-Palatinate, 67550, Germany
-
Klinikum der Universität München
RECRUITINGMünchen, Bavaria, 80336, Germany
-
Klinikum-Mittelbaden GmbH, Studienzentrale/Brustzentrum
RECRUITINGBaden-Baden, Baden-Wurttemberg, 76532, Germany
-
Krankenhaus St. Elisabeth und St. Barbara Halle/Saale
RECRUITINGHalle, Saxony-Anhalt, 06110, Germany
-
Luisenkrankenhaus GmbH Co KG
RECRUITINGDüsseldorf, North Rhine-Westphalia, 40235, Germany
-
MKS St. Paulus Schwerte (ehemals Marienkrankenhaus)
ACTIVE_NOT_RECRUITINGSchwerte, Germany
-
Marien Hospital Düsseldorf
RECRUITINGDüsseldorf, North Rhine-Westphalia, 40479, Germany
-
Marienhospital Aachen
RECRUITINGAachen, North Rhine-Westphalia, 52066, Germany
-
Marienhospital, Klinik für Gynäkologie und Geburtshilfe
RECRUITINGBottrop, Germany
-
Mathias-Spital-Rheine
RECRUITINGRheine, North Rhine-Westphalia, 48431, Germany
-
Med. Zentrum f. Hämatologie und Onkologie München
ACTIVE_NOT_RECRUITINGMünchen, Bavaria, 80639, Germany
-
Medias Klinikum
ACTIVE_NOT_RECRUITINGBurghausen, Bavaria, 84489, Germany
-
Medionko - Praxisklinik Krebsheilkunde Frauen
ACTIVE_NOT_RECRUITINGBerlin, State of Berlin, 10367, Germany
-
Onkologische Praxis Oldenburg, Gemeinschaftspraxis für Innere Medizin, Hämatologie und Onkologie
RECRUITINGOldenburg, Lower Saxony, 26121, Germany
-
Praxisnetzwerk Hämatologie/int. Onkologie
RECRUITINGTroisdorf, North Rhine-Westphalia, 53840, Germany
-
St. Antonius Hospital Kleve (Katholisches Kral Leistner Zentrum)
RECRUITINGGoch, North Rhine-Westphalia, 47574, Germany
-
St. Barbara Klinik
RECRUITINGHamm, North Rhine-Westphalia, 59073, Germany
-
St. Franziskus-Hospital
RECRUITINGMünster, North Rhine-Westphalia, 48145, Germany
-
St. Gertrauden Krankenhaus Brustzentrum City Berlin
RECRUITINGBerlin, State of Berlin, 10713, Germany
-
St. Josefs-Hospital Wiesbaden GmbH
RECRUITINGWiesbaden, Hesse, 65189, Germany
-
St. Vincenz-Krankenhaus Datteln
RECRUITINGDatteln, North Rhine-Westphalia, 45711, Germany
-
Studienzentrum Onkologie Ravensburg
RECRUITINGRavensburg, Baden-Wüttemberg, 88212, Germany
-
Studienzentrum Untere Ems
RECRUITINGLeer, Lower Saxony, 26789, Germany
-
Universitaetsklinikum Muenster
RECRUITINGMünster, North Rhine-Westphalia, 48149, Germany
-
Universität Marburg, Klinik für Frauenheilkunde, Brustzentrum
ACTIVE_NOT_RECRUITINGMarburg, Hesse, 35043, Germany
-
Universitätsfrauenklinik Ulm - Frauenheilkunde und Geburtshilfe
RECRUITINGUlm, Baden-Wurttemberg, 89075, Germany
-
Universitätsklinikum Augsburg, Brustzentrum
RECRUITINGAugsburg, Bavaria, 86156, Germany
-
Universitätsklinikum Bonn Frauenheilkunde
ACTIVE_NOT_RECRUITINGBonn, North Rhine-Westphalia, 53127, Germany
-
Universitätsklinikum Bonn, Senologie
RECRUITINGBonn, North Rhine-Westphalia, 53127, Germany
-
Universitätsklinikum Erlangen
ACTIVE_NOT_RECRUITINGErlangen, Erlangen, 91054, Germany
-
ViDia Christliche Kliniken Karlsruhe
RECRUITINGKarlsruhe, Baden-Wüttemberg, 76135, Germany
-
Ärztehaus am Bahnhofsplatz
RECRUITINGHildesheim, Lower Saxony, 31134, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill giredestrant put to the test for sticking with breast cancer treatment
- Could a diabetes drug slow breast cancer growth?
- Young breast cancer patients share views on fertility risks in new survey
- Older women with Low-Risk breast cancer may avoid unnecessary surgery
- Could a pill replace chemo for some breast cancer patients?
- Scientists Re-Analyze old samples to unlock secrets of HER2-Low breast cancer